CR20190211A - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator - Google Patents
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorInfo
- Publication number
- CR20190211A CR20190211A CR20190211A CR20190211A CR20190211A CR 20190211 A CR20190211 A CR 20190211A CR 20190211 A CR20190211 A CR 20190211A CR 20190211 A CR20190211 A CR 20190211A CR 20190211 A CR20190211 A CR 20190211A
- Authority
- CR
- Costa Rica
- Prior art keywords
- modulator
- methods
- making
- pharmaceutical compositions
- cystic fibrosis
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compounds of Formula (I), pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.Compuestos de Fórmula I: sales farmacéuticamente aceptables de este, derivados deuterados de cualquiera de los precedentes y metabolitos de cualquiera de los precedentes se describen. También se describen composiciones farmacéuticas que los comprenden, métodos para tratar la fibrosis quística usándolos y métodos para producirlos.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662402838P | 2016-09-30 | 2016-09-30 | |
| US201662410353P | 2016-10-19 | 2016-10-19 | |
| US201662415409P | 2016-10-31 | 2016-10-31 | |
| PCT/US2017/054611 WO2018064632A1 (en) | 2016-09-30 | 2017-09-29 | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20190211A true CR20190211A (en) | 2019-07-11 |
Family
ID=67910532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20190211A CR20190211A (en) | 2016-09-30 | 2017-09-29 | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR20190211A (en) |
-
2017
- 2017-09-29 CR CR20190211A patent/CR20190211A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY38093A (en) | CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND PREPARATION PROCESS OF MODULATORS | |
| CO2019004065A2 (en) | Cystic fibrosis transmembrane conductance regulator modulator, pharmaceutical compositions, treatment methods and process to produce the modulator | |
| UY39723A (en) | CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND PROCESS FOR PRODUCING THE MODULATOR | |
| CO2021014204A2 (en) | Cystic fibrosis transmembrane conductance regulator modulating agents | |
| NZ730794A (en) | Modulators of cystic fibrosis transmembrane conductance regulator | |
| TN2018000175A1 (en) | Indane derivatives as mglur7 modulators | |
| CR20190211A (en) | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator | |
| EA201990850A1 (en) | MODULATOR OF A FLOW-MOVICIDE TRANSMEMBRANE CONDUCTIVITY REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHODS OF PRODUCING A MODULATOR | |
| NZ754805B2 (en) | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |